EC Gynaecology

Takotsubo cardiomyopathy, often referred to as broke heart syndrome, apical balloon syndrome, or stress cardiomyopathy, occurs when a stressful emotional or physical event causes the left ventricle of the heart to enlarge, resulting in sudden heart failure. The condition was initially reported in Japan in 1990. Catecholamine drive is critical in the development and pathophysiology of Takotsubo cardiomyopathy.

Supportive and symptomatic medicine remains the basis of therapy, with a focus on increasing left ventricular function for several days and complete recovery in 3 - 4 weeks. Takotsubo cardiomyopathy, which is comparable to myocardial infarction, need a rigorous diagnosis and therapy to provide the best possible outcome.

This abstract highlights the importance of recognizing Takotsubo cardiomyopathy in clinical practice, particularly in high-stress scenarios such as surgical procedures, to ensure timely and effective management. Further research is warranted to elucidate the underlying mechanisms and improve therapeutic approaches for this intriguing cardiac phenomenon.

 Keywords: Takotsubo; Broken Heart; Cardiomyopathy; Caesarean Section; Reversible

1. Akashi YJ and Ishihara M. “Takotsubo syndrome: insights from Japan”. Heart Failure Clinics4 (2016): 587-595.
2. Patankar GR., et al. “Reverse takotsubo cardiomyopathy: two case reports and review of the literature”. Journal of Medical Case Reports 7 (2013): 84.
3. Sharkey SW., et al. “Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature”. Journal of the American College of Cardiology13 (2011): 1496-1497.
4. Dote K., et al. “Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases”. Journal of Cardiology2 (1991): 203-214.
5. Gianni M., et al. “Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review”. European Heart Journal13 (2006): 1523-1529.
6. Jabri A., et al. “Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic”. JAMA Network Open7 (2020): e2014780.
7. Schneider B., et al. “Gender differences in the manifestation of tako-tsubo cardiomyopathy”. International Journal of Cardiology 3 (2013): 584-588.
8. Templin C., et al. “Clinical features and outcomes of takotsubo (stress) cardiomyopathy”. New England Journal of Medicine10 (2015): 929-938.
9. Pelliccia F., et al. “Pathophysiology of Takotsubo syndrome”. Circulation24 (2017): 2426-2441.
10. Ueyama T., et al. “Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart”. Circulation Journal4 (2007): 565-573.
11. Kuo BT., et al. “Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy”. Gender Medicine1 (2010): 71-77.
12. Scantlebury DC and Prasad A. “Diagnosis of takotsubo cardiomyopathy-Mayo Clinic criteria”. Circulation Journal9 (2014): 2129-2139.
13. Ghadri J-R., et al. “International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology”. European Heart Journal22 (2018): 2032-2046.
14. Medina de Chazal H., et al. “Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review”. Journal of the American College of Cardiology16 (2018): 1955-1971.
15. Struthers AD. “Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?” British Journal of Clinical Pharmacology5 (1999): 479-482.
16. Barrera-Ramirez C., et al. “Apical thrombus associated with left ventricular apical ballooning”. Heart8 (2003): 927.
17. Singh K., et al. “Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy”. International Journal of Cardiology3 (2014): 696-701.